Fine Needle Aspiration of the Thyroid

Chapter
Part of the Endocrine Updates book series (ENDO, volume 32)

Abstract

Fine-needle-aspiration biopsy (FNAB) is a safe and inexpensive procedure that is easily performed with minimal patient discomfort. It has become the cornerstone in the management of patients with thyroid nodules; its main purpose is to provide a rational approach to management, to triage individuals for surgical management, and to determine the correct surgical procedure – lobectomy versus total thyroidectomy. FNAB has successfully reduced the number of patients requiring surgery by 50%, has increased the yield of thyroid malignancy at surgery by two to three times, and has decreased the cost of managing thyroid nodules by 25%.

Keywords

Fine-needle-aspiration biopsy Thyroid nodules Thyroid malignancy Bethesda classification Ultrasound guidance Specimen evaluation 

References

  1. 1.
    Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:109–42.PubMedGoogle Scholar
  2. 2.
    Yang J, Schnadig V, Logrono R, Wasserman PG. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer. 2007;111:306–15.PubMedGoogle Scholar
  3. 3.
    Goldstein RE, Netterville JL, Burkey B. Johnson JE Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules. Ann Surg. 2002;235:656–62. discussion 662–654.PubMedGoogle Scholar
  4. 4.
    Miller JM, Hamburger JI, Kini SR. The impact of needle biopsy on the preoperative diagnosis of thyroid nodules. Henry Ford Hosp Med J. 1980;28:145–8.PubMedGoogle Scholar
  5. 5.
    Clark DPF, Faquin WC. Thyroid cytopathology. Springer: New York; 2005.Google Scholar
  6. 6.
    Pothier DD, Narula AA. Should we apply suction during fine needle cytology of thyroid lesions? A systematic review and meta-analysis. Ann R Coll Surg Engl. 2006;88:643–5.PubMedCentralPubMedGoogle Scholar
  7. 7.
    de Vos tot Nederveen Cappel RJ, Bouvy ND, Bonjer HJ, van Muiswinkel JM, Chadha S. Fine needle aspiration cytology of thyroid nodules: how accurate is it and what are the causes of discrepant cases? Cytopathology. 2001;12:399–405.Google Scholar
  8. 8.
    Hall TL, Layfield LJ, Philippe A, Rosenthal DL. Sources of diagnostic error in fine needle aspiration of the thyroid. Cancer. 1989;63:718–25.PubMedGoogle Scholar
  9. 9.
    Ljung BM, Drejet A, Chiampi N, Jeffrey J, Goodson 3 WH, Chew K, et al. Diagnostic accuracy of fine-needle aspiration biopsy is determined by physician training in sampling technique. Cancer. 2001;93:263–8.PubMedGoogle Scholar
  10. 10.
    Unver E, Yilmaz A, Aksoy F, Baysungur V, Celik O, Altinsoy B, et al. Does needle size affect diagnostic yield of transthoracic needle biopsy in malignant pulmonary lesions? Comparison of 18-, 22- and 25-gauge needles in surgical specimens. Respirology. 2006;11:648–51.PubMedGoogle Scholar
  11. 11.
    Zajdela A, de Maublanc MA, Schlienger P, Haye C. Cytologic diagnosis of orbital and periorbital palpable tumors using fine-needle sampling without aspiration. Diagn Cytopathol. 1986;2:17–20.PubMedGoogle Scholar
  12. 12.
    Alexander EK, Heering JP, Benson CB, Frates MC, Doubilet PM, Cibas ES, et al. Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules. J Clin Endocrinol Metab. 2002;87:4924–7.PubMedGoogle Scholar
  13. 13.
    Cajulis RS, Sneige N. Objective comparison of cellular yield in fine-needle biopsy of lymph nodes with and without aspiration. Diagn Cytopathol. 1993;9:43–5.PubMedGoogle Scholar
  14. 14.
    Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol. 2009;132:658–65.PubMedGoogle Scholar
  15. 15.
    Redman R, Zalaznick H, Mazzaferri EL, Massoll NA. The impact of assessing specimen adequacy and number of needle passes for fine-needle aspiration biopsy of thyroid nodules. Thyroid. 2006;16:55–60.PubMedGoogle Scholar
  16. 16.
    Zhu W, Michael CW. How important is on-site adequacy assessment for thyroid FNA? An evaluation of 883 cases. Diagn Cytopathol. 2007;35:183–6.PubMedGoogle Scholar
  17. 17.
    Nasuti JF, Gupta PK, Baloch ZW. Diagnostic value and cost-effectiveness of on-site evaluation of fine-needle aspiration specimens: review of 5,688 cases. Diagn Cytopathol. 2002;27:1–4.PubMedGoogle Scholar
  18. 18.
    Ghofrani M, Beckman D, Rimm DL. The value of onsite adequacy assessment of thyroid fine-needle aspirations is a function of operator experience. Cancer. 2006;108:110–3.PubMedGoogle Scholar
  19. 19.
    Baloch ZW, LiVolsi VA. Post fine-needle aspiration histologic alterations of thyroid revisited. Am J Clin Pathol. 1999;112:311–6.PubMedGoogle Scholar
  20. 20.
    Baloch ZW, Wu H, LiVolsi VA. Post-fine-needle aspiration spindle cell nodules of the thyroid (PSCNT). Am J Clin Pathol. 1999;111:70–4.PubMedGoogle Scholar
  21. 21.
    LiVolsi VA, Merino MJ. Worrisome histologic alterations following fine-needle aspiration of the thyroid (WHAFFT). Pathol Annu. 1994;29(Pt 2):99–120.PubMedGoogle Scholar
  22. 22.
    Kini SR. Post-fine-needle biopsy infarction of thyroid neoplasms: a review of 28 cases. Diagn Cytopathol. 1996;15:211–20.PubMedGoogle Scholar
  23. 23.
    Gordon DL, Gattuso P, Castelli M, Bayer W, Emanuele MA, Brooks MH. Effect of fine needle aspiration biopsy on the histology of thyroid neoplasms. Acta Cytol. 1993;37:651–4.PubMedGoogle Scholar
  24. 24.
    Karwowski JK, Nowels KW, McDougall IR, Weigel RJ. Needle track seeding of papillary thyroid carcinoma from fine needle aspiration biopsy. A case report. Acta Cytol. 2002;46:591–5.PubMedGoogle Scholar
  25. 25.
    Amrikachi M, Ramzy I, Rubenfeld S, Wheeler TM. Accuracy of fine-needle aspiration of thyroid. Arch Pathol Lab Med. 2001;125:484–8.PubMedGoogle Scholar
  26. 26.
    Gharib H. Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations, and effect. Mayo Clin Proc. 1994;69:44–9.PubMedGoogle Scholar
  27. 27.
    Harvey JN, Parker D, De P, Shrimali RK, Otter M. Sonographically guided core biopsy in the assessment of thyroid nodules. J Clin Ultrasound. 2005;33:57–62.PubMedGoogle Scholar
  28. 28.
    Baloch ZW, LiVolsi VA. Fine-needle aspiration of thyroid nodules: past, present, and future. Endocr Pract. 2004;10:234–41.PubMedGoogle Scholar
  29. 29.
    Granter SR, Cibas ES. Cytologic findings in thyroid nodules after 131I treatment of hyperthyroidism. Am J Clin Pathol. 1997;107:20–5.PubMedGoogle Scholar
  30. 30.
    Pretorius HT, Katikineni M, Kinsella TJ, Barsky SH, Brennan MF, Chu EW, et al. Thyroid nodules after high-dose external radiotherapy. Fine-needle aspiration cytology in diagnosis and management. JAMA. 1982;247:3217–20.PubMedGoogle Scholar
  31. 31.
    Kollur SM, El Sayed S, El Hag IA. Follicular thyroid lesions coexisting with Hashimoto’s thyroiditis: incidence and possible sources of diagnostic errors. Diagn Cytopathol. 2003;28:35–8.PubMedGoogle Scholar
  32. 32.
    Nguyen GK, Ginsberg J, Crockford PM, Villanueva RR. Hashimoto’s thyroiditis: cytodiagnostic accuracy and pitfalls. Diagn Cytopathol. 1997;16:531–6.PubMedGoogle Scholar
  33. 33.
    Kini SR, Miller JM, Hamburger JI, Smith-Purslow MJ. Cytopathology of follicular lesions of the thyroid gland. Diagn Cytopathol. 1985;1:123–32.PubMedGoogle Scholar
  34. 34.
    Goellner JR, Gharib H, Grant CS, Johnson DA. Fine needle aspiration cytology of the thyroid, 1980 to 1986. Acta Cytol. 1987;31:587–90.PubMedGoogle Scholar
  35. 35.
    Hamburger JI, Husain M. Semiquantitative criteria for fine-needle biopsy diagnosis: reduced false-negative diagnoses. Diagn Cytopathol. 1988;4:14–7.PubMedGoogle Scholar
  36. 36.
    Nguyen GK, Ginsberg J, Crockford PM. Fine-needle aspiration biopsy cytology of the thyroid. Its value and limitations in the diagnosis and management of solitary thyroid nodules. Pathol Annu. 1991;26(Pt 1):63–91.PubMedGoogle Scholar
  37. 37.
    Shabb NS, Salti I. Subacute thyroiditis: fine-needle aspiration cytology of 14 cases presenting with thyroid nodules. Diagn Cytopathol. 2006;34:18–23.PubMedGoogle Scholar
  38. 38.
    Guidelines of the Papanicolaou Society of Cytopathology for the Examination of Fine-Needle Aspiration Specimens from Thyroid Nodules. The Papanicolaou Society of Cytopathology Task Force on Standards of Practice. Mod Pathol. 1996;9:710–5Google Scholar
  39. 39.
    Deshpande V, Kapila K, Sai K, Verma K. Follicular neoplasms of the thyroid. Decision tree approach using morphologic and morphometric parameters. Acta Cytol. 1997;41:369–76.PubMedGoogle Scholar
  40. 40.
    Renshaw AA. Accuracy of thyroid fine-needle aspiration using receiver operator characteristic curves. Am J Clin Pathol. 2001;116:477–82.PubMedGoogle Scholar
  41. 41.
    Renshaw AA. Evidence-based criteria for adequacy in thyroid fine-needle aspiration. Am J Clin Pathol. 2002;118:518–21.PubMedGoogle Scholar
  42. 42.
    Wang HH. Reporting thyroid fine-needle aspiration: literature review and a proposal. Diagn Cytopathol. 2006;34:67–76.PubMedGoogle Scholar
  43. 43.
    Yassa L, Cibas ES, Benson CB, Frates MC, Doubilet PM, Gawande AA, et al. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer. 2007;111:508–16.PubMedGoogle Scholar
  44. 44.
    Liu LH, Bakhos R, Wojcik EM. Concomitant papillary thyroid carcinoma and Hashimoto’s thyroiditis. Semin Diagn Pathol. 2001;18:99–103.PubMedGoogle Scholar
  45. 45.
    Moshynska OV, Saxena A. Clonal relationship between Hashimoto thyroiditis and thyroid lymphoma. J Clin Pathol. 2008;61:438–44.PubMedGoogle Scholar
  46. 46.
    Kumar N, Ray C, Jain S. Aspiration cytology of Hashimoto’s thyroiditis in an endemic area. Cytopathology. 2002;13:31–9.PubMedGoogle Scholar
  47. 47.
    Kini SR. Thyroid cytopathology: an atlas and text. Philadelphia, PA: Lippincott Williams & Wilkins; 2008. A Wolters Kluwer business.Google Scholar
  48. 48.
    Kojima M, Nakamura N, Shimizu K, Segawa A, Kaba S, Masawa N. MALT type lymphoma demonstrating prominent plasma cell differentiation resembling fibrous variant of Hashimoto’s thyroiditis: a three case report. Pathol Oncol Res. 2009;15:285–9.PubMedGoogle Scholar
  49. 49.
    MacDonald L, Yazdi HM. Fine needle aspiration biopsy of Hashimoto’s thyroiditis. Sources of diagnostic error. Acta Cytol. 1999;43:400–6.PubMedGoogle Scholar
  50. 50.
    Kumarasinghe MP, De Silva S. Pitfalls in cytological diagnosis of autoimmune thyroiditis. Pathology. 1999;31:1–7.PubMedGoogle Scholar
  51. 51.
    Anderson SR, Mandel S, LiVolsi VA, Gupta PK, Baloch ZW. Can cytomorphology differentiate between benign nodules and tumors arising in Graves’ disease? Diagn Cytopathol. 2004;31:64–7.PubMedGoogle Scholar
  52. 52.
    Harach HR, Zusman SB, Saravia Day E. Nodular goiter: a histo-cytological study with some emphasis on pitfalls of fine-needle aspiration cytology. Diagn Cytopathol. 1992;8:409–19.PubMedGoogle Scholar
  53. 53.
    Sidawy MK, Del Vecchio DM, Knoll SM. Fine-needle aspiration of thyroid nodules: correlation between cytology and histology and evaluation of discrepant cases. Cancer. 1997;81:253–9.PubMedGoogle Scholar
  54. 54.
    Busseniers AE, Oertel YC. “Cellular adenomatoid nodules” of the thyroid: review of 219 fine-needle aspirates. Diagn Cytopathol. 1993;9:581–9.PubMedGoogle Scholar
  55. 55.
    Fiorella RM, Isley W, Miller LK, Kragel PJ. Multinodular goiter of the thyroid mimicking malignancy: diagnostic pitfalls in fine-needle aspiration biopsy. Diagn Cytopathol. 1993;9:351–5. discussion 355–57.PubMedGoogle Scholar
  56. 56.
    Thompson LD, Wieneke JA, Paal E, Frommelt RA, Adair CF, Heffess CS. A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer. 2001;91:505–24.PubMedGoogle Scholar
  57. 57.
    Suster S. Thyroid tumors with a follicular growth pattern: problems in differential diagnosis. Arch Pathol Lab Med. 2006;130:984–8.PubMedGoogle Scholar
  58. 58.
    LiVolsi VA, Baloch ZW. Follicular neoplasms of the thyroid: view, biases, and experiences. Adv Anat Pathol. 2004;11:279–87.PubMedGoogle Scholar
  59. 59.
    Evenson A, Mowschenson P, Wang H, Connolly J, Mendrinos S, Parangi S, et al. Hyalinizing trabecular adenoma – an uncommon thyroid tumor frequently misdiagnosed as papillary or medullary thyroid carcinoma. Am J Surg. 2007;193:707–12.PubMedGoogle Scholar
  60. 60.
    Galgano MT, Mills SE, Stelow EB. Hyalinizing trabecular adenoma of the thyroid revisited: a histologic and immunohistochemical study of thyroid lesions with prominent trabecular architecture and sclerosis. Am J Surg Pathol. 2006;30:1269–73.PubMedGoogle Scholar
  61. 61.
    Carney JA, Hirokawa M, Lloyd RV, Papotti M, Sebo TJ. Hyalinizing trabecular tumors of the thyroid gland are almost all benign. Am J Surg Pathol. 2008;32:1877–89.PubMedGoogle Scholar
  62. 62.
    Casey MB, Sebo TJ, Carney JA. Hyalinizing trabecular adenoma of the thyroid gland: cytologic features in 29 cases. Am J Surg Pathol. 2004;28:859–67.PubMedGoogle Scholar
  63. 63.
    Kuma S, Hirokawa M, Miyauchi A, Kakudo K, Katayama S. Cytologic features of hyalinizing trabecular adenoma of the thyroid. Acta Cytol. 2003;47:399–404.PubMedGoogle Scholar
  64. 64.
    Jayaram G. Fine needle aspiration cytology of hyalinizing trabecular adenoma of the thyroid. Acta Cytol. 1999;43:978–80.PubMedGoogle Scholar
  65. 65.
    LiVolsi VA, Gupta PK. Thyroid fine-needle aspiration: intranuclear inclusions, nuclear grooves and psammoma bodies – paraganglioma-like adenoma of the thyroid. Diagn Cytopathol. 1992;8:82–3. discussion 83–4.PubMedGoogle Scholar
  66. 66.
    Hirokawa M, Carney JA. Cell membrane and cytoplasmic staining for MIB-1 in hyalinizing trabecular adenoma of the thyroid gland. Am J Surg Pathol. 2000;24:575–8.PubMedGoogle Scholar
  67. 67.
    Hirokawa M, Shimizu M, Manabe T, Kuroda M, Mizoguchi Y. Hyalinizing trabecular adenoma of the thyroid: its unusual cytoplasmic immunopositivity for MIB1. Pathol Int. 1995;45:399–401.PubMedGoogle Scholar
  68. 68.
    Carcangiu ML, Bianchi S, Savino D, Voynick IM, Rosai J. Follicular Hurthle cell tumors of the thyroid gland. Cancer. 1991;68:1944–53.PubMedGoogle Scholar
  69. 69.
    Elliott DD, Pitman MB, Bloom L, Faquin WC. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: a cytomorphologic study of 139 cases with statistical analysis. Cancer. 2006;108:102–9.PubMedGoogle Scholar
  70. 70.
    Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer. 1985;55:805–28.PubMedGoogle Scholar
  71. 71.
    Al-Brahim N, Asa SL. Papillary thyroid carcinoma: an overview. Arch Pathol Lab Med. 2006;130:1057–62.PubMedGoogle Scholar
  72. 72.
    Oertel YC, Oertel JE. Thyroid cytology and histology. Baillieres Best Pract Res Clin Endocrinol Metab. 2000;14:541–57.PubMedGoogle Scholar
  73. 73.
    Szporn AH, Yuan S, Wu M, Burstein DE. Cellular swirls in fine needle aspirates of papillary thyroid carcinoma: a new diagnostic criterion. Mod Pathol. 2006;19:1470–3.PubMedGoogle Scholar
  74. 74.
    Albores-Saavedra J, Wu J. The many faces and mimics of papillary thyroid carcinoma. Endocr Pathol. 2006;17:1–18.PubMedGoogle Scholar
  75. 75.
    Das DK. Intranuclear cytoplasmic inclusions in fine-needle aspiration smears of papillary thyroid carcinoma: a study of its morphological forms, association with nuclear grooves, and mode of formation. Diagn Cytopathol. 2005;32:264–8.PubMedGoogle Scholar
  76. 76.
    Tielens ET, Sherman SI, Hruban RH, Ladenson PW. Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer. 1994;73:424–31.PubMedGoogle Scholar
  77. 77.
    Baloch ZW, Gupta PK, Yu GH, Sack MJ, LiVolsi VA. Follicular variant of papillary carcinoma. Cytologic and histologic correlation. Am J Clin Pathol. 1999;111:216–22.PubMedGoogle Scholar
  78. 78.
    El Hag IA, Kollur SM. Benign follicular thyroid lesions versus follicular variant of papillary carcinoma: differentiation by architectural pattern. Cytopathology. 2004;15:200–5.PubMedGoogle Scholar
  79. 79.
    Gallagher J, Oertel YC, Oertel JE. Follicular variant of papillary carcinoma of the thyroid: fine-needle aspirates with histologic correlation. Diagn Cytopathol. 1997;16:207–13.PubMedGoogle Scholar
  80. 80.
    Renshaw AA, Gould EW. Why there is the tendency to “overdiagnose” the follicular variant of papillary thyroid carcinoma. Am J Clin Pathol. 2002;117:19–21.PubMedGoogle Scholar
  81. 81.
    Filie AC, Chiesa A, Bryant BR, Merino MJ, Sobel ME, Abati A. The Tall cell variant of papillary carcinoma of the thyroid: cytologic features and loss of heterozygosity of metastatic and/or recurrent neoplasms and primary neoplasms. Cancer. 1999;87:238–42.PubMedGoogle Scholar
  82. 82.
    Ostrowski ML, Merino MJ. Tall cell variant of papillary thyroid carcinoma: a reassessment and immunohistochemical study with comparison to the usual type of papillary carcinoma of the thyroid. Am J Surg Pathol. 1996;20:964–74.PubMedGoogle Scholar
  83. 83.
    Gamboa-Dominguez A, Candanedo-Gonzalez F, Uribe-Uribe NO, Angeles-Angeles A. Tall cell variant of papillary thyroid carcinoma. A cytohistologic correlation. Acta Cytol. 1997;41:672–6.PubMedGoogle Scholar
  84. 84.
    Das DK, Mallik MK, Sharma P, Sheikh ZA, Mathew PA, Sheikh M, et al. Papillary thyroid carcinoma and its variants in fine needle aspiration smears. A cytomorphologic study with special reference to tall cell variant. Acta Cytol. 2004;48:325–36.PubMedGoogle Scholar
  85. 85.
    Ferreiro JA, Hay ID, Lloyd RV. Columnar cell carcinoma of the thyroid: report of three additional cases. Hum Pathol. 1996;27:1156–60.PubMedGoogle Scholar
  86. 86.
    Mizukami Y, Nonomura A, Michigishi T, Noguchi M, Nakamura S, Hashimoto T. Columnar cell carcinoma of the thyroid gland: a case report and review of the literature. Hum Pathol. 1994;25:1098–101.PubMedGoogle Scholar
  87. 87.
    Jayaram G. Cytology of columnar-cell variant of papillary thyroid carcinoma. Diagn Cytopathol. 2000;22:227–9.PubMedGoogle Scholar
  88. 88.
    Wenig BM, Thompson LD, Adair CF, Shmookler B, Heffess CS. Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases. Cancer. 1998;82:740–53.PubMedGoogle Scholar
  89. 89.
    Fujimoto Y, Obara T, Ito Y, Kodama T, Aiba M, Yamaguchi K. Diffuse sclerosing variant of papillary carcinoma of the thyroid. Clinical importance, surgical treatment, and follow-up study. Cancer. 1990;66:2306–12.PubMedGoogle Scholar
  90. 90.
    Triggiani V, Ciampolillo A, Maiorano E. Papillary thyroid carcinoma, diffuse sclerosing variant, with abundant psammoma bodies. Acta Cytol. 2003;47:1141–3.PubMedGoogle Scholar
  91. 91.
    Caplan RH, Wester S, Kisken AW. Diffuse sclerosing variant of papillary thyroid carcinoma: case report and review of the literature. Endocr Pract. 1997;3:287–92.PubMedGoogle Scholar
  92. 92.
    Berho M, Suster S. The oncocytic variant of papillary carcinoma of the thyroid: a clinicopathologic study of 15 cases. Hum Pathol. 1997;28:47–53.PubMedGoogle Scholar
  93. 93.
    Beckner ME, Heffess CS, Oertel JE. Oxyphilic papillary thyroid carcinomas. Am J Clin Pathol. 1995;103:280–7.PubMedGoogle Scholar
  94. 94.
    Khanum O, Wang S, Hameed A. Fine needle aspiration cytology of a papillary oncocytic neoplasm of the thyroid gland. Acta Cytol. 1999;43:976–8.PubMedGoogle Scholar
  95. 95.
    Akslen LA, LiVolsi VA. Prognostic significance of histologic grading compared with subclassification of papillary thyroid carcinoma. Cancer. 2000;88:1902–8.PubMedGoogle Scholar
  96. 96.
    Johnson TL, Lloyd RV, Thompson NW, Beierwaltes WH, Sisson JC. Prognostic implications of the tall cell variant of papillary thyroid carcinoma. Am J Surg Pathol. 1988;12:22–7.PubMedGoogle Scholar
  97. 97.
    van den Brekel MW, Hekkenberg RJ, Asa SL, Tomlinson G, Rosen IB, Freeman JL. Prognostic features in tall cell papillary carcinoma and insular thyroid carcinoma. Laryngoscope. 1997;107:254–9.PubMedGoogle Scholar
  98. 98.
    Herrera MF, Hay ID, Wu PS, Goellner JR, Ryan JJ, Ebersold JR, et al. Hurthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior. World J Surg. 1992;16:669–74. discussion 774–665.PubMedGoogle Scholar
  99. 99.
    Imamura Y, Kasahara Y, Fukuda M. Multiple brain metastases from a diffuse sclerosing variant of papillary carcinoma of the thyroid. Endocr Pathol. 2000;11:97–108.PubMedGoogle Scholar
  100. 100.
    Gupta S, Sodhani P, Jain S, Kumar N. Morphologic spectrum of papillary carcinoma of the thyroid: role of cytology in identifying the variants. Acta Cytol. 2004;48:795–800.PubMedGoogle Scholar
  101. 101.
    Nair M, Kapila K, Karak AK, Verma K. Papillary carcinoma of the thyroid and its variants: a cytohistological correlation. Diagn Cytopathol. 2001;24:167–73.PubMedGoogle Scholar
  102. 102.
    Baloch ZW, LiVolsi VA. Cytologic and architectural mimics of papillary thyroid carcinoma Diagnostic challenges in fine-needle aspiration and surgical pathology specimens. Am J Clin Pathol. 2006;125(Suppl):S135–44.PubMedGoogle Scholar
  103. 103.
    Fletcher JR. Medullary (solid) carcinoma of the thyroid gland. A review of 249 cases. Arch Surg. 1970;100:257–62.PubMedGoogle Scholar
  104. 104.
    Williams ED. A review of 17 cases of carcinoma of the thyroid and phaeochromocytoma. J Clin Pathol. 1965;18:288–92.PubMedGoogle Scholar
  105. 105.
    Williams ED. The origin and associations of medullary carcinoma of the thyroid. Monogr Neoplast Dis Var Sites. 1970;6:130–40.PubMedGoogle Scholar
  106. 106.
    Williams CR, Brewer DB. Medullary carcinoma of the thyroid. Br J Surg. 1969;56:437–43.PubMedGoogle Scholar
  107. 107.
    Collins BT, Cramer HM, Tabatowski K, Hearn S, Raminhos A, Lampe H. Fine needle aspiration of medullary carcinoma of the thyroid. Cytomorphology, immunocytochemistry and electron microscopy. Acta Cytol. 1995;39:920–30.PubMedGoogle Scholar
  108. 108.
    Papaparaskeva K, Nagel H, Droese M. Cytologic diagnosis of medullary carcinoma of the thyroid gland. Diagn Cytopathol. 2000;22:351–8.PubMedGoogle Scholar
  109. 109.
    Bose S, Kapila K, Verma K. Medullary carcinoma of the thyroid: a cytological, immunocytochemical, and ultrastructural study. Diagn Cytopathol. 1992;8:28–32.PubMedGoogle Scholar
  110. 110.
    Forrest CH, Frost FA, de Boer WB, Spagnolo DV, Whitaker D, Sterrett BF. Medullary carcinoma of the thyroid: accuracy of diagnosis of fine-needle aspiration cytology. Cancer. 1998;84:295–302.PubMedGoogle Scholar
  111. 111.
    McIver B, Hay ID, Giuffrida DF, Dvorak CE, Grant CS, Thompson GB, et al. Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery. 2001;130:1028–34.PubMedGoogle Scholar
  112. 112.
    Us-Krasovec M, Golouh R, Auersperg M, Besic N, Ruparcic-Oblak L. Anaplastic thyroid carcinoma in fine needle aspirates. Acta Cytol. 1996;40:953–8.PubMedGoogle Scholar
  113. 113.
    Bauman ME, Tao LC. Cytopathology of papillary carcinoma of the thyroid with anaplastic transformation. A case report. Acta Cytol. 1995;39:525–9.PubMedGoogle Scholar
  114. 114.
    Shvero J, Gal R, Avidor I, Hadar T, Kessler E. Anaplastic thyroid carcinoma. A clinical, histologic, and immunohistochemical study. Cancer. 1988;62:319–25.PubMedGoogle Scholar
  115. 115.
    Sclabas GM, Staerkel GA, Shapiro SE, Fornage BD, Sherman SI, Vassillopoulou-Sellin R, et al. Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients. Am J Surg. 2003;186:702–9. discussion 709–710.PubMedGoogle Scholar
  116. 116.
    Adeniran AJ, Zhu Z, Gandhi M, Steward DL, Fidler JP, Giordano TJ, et al. Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol. 2006;30:216–22.PubMedGoogle Scholar
  117. 117.
    Xing M. BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev. 2007;28:742–62.PubMedGoogle Scholar
  118. 118.
    Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res. 2003;63:1454–7.PubMedGoogle Scholar
  119. 119.
    Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn 2nd GW, Tallini G, et al. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab. 2003;88:2318–26.PubMedGoogle Scholar
  120. 120.
    Pizzolanti G, Russo L, Richiusa P, Bronte V, Nuara RB, Rodolico V, et al. Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement. Thyroid. 2007;17:1109–15.PubMedGoogle Scholar
  121. 121.
    Sapio MR, Posca D, Raggioli A, Guerra A, Marotta V, Deandrea M, et al. Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. Clin Endocrinol (Oxf). 2007;66:678–83.Google Scholar
  122. 122.
    Sapio MR, Posca D, Troncone G, Pettinato G, Palombini L, Rossi G, et al. Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA). Eur J Endocrinol. 2006;154:341–8.PubMedGoogle Scholar
  123. 123.
    Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab. 2009;94:2092–8.PubMedGoogle Scholar
  124. 124.
    Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE. MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab. 2008;93:1600–8.PubMedGoogle Scholar
  125. 125.
    Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857–66.PubMedGoogle Scholar
  126. 126.
    Weber F, Teresi RE, Broelsch CE, Frilling A, Eng C. A limited set of human MicroRNA is deregulated in follicular thyroid carcinoma. J Clin Endocrinol Metab. 2006;91:3584–91.PubMedGoogle Scholar
  127. 127.
    Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, et al. MicroRNA deregulation in human thyroid papillary carcinomas. Endocr Relat Cancer. 2006;13:497–508.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of Pathology and Lab MedicineCedars-Sinai Medical CenterLos AngelesUSA

Personalised recommendations